Use of Tinzaparin for Anticoagulation in Hemodialysis
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The HEMO-TIN trial is designed to look at both the safety (bleeding risk) and effectiveness
(clotting risk) of tinzaparin compared with unfractionated heparin for anticoagulation in
hemodialysis patients.